Timo Minssen

Timo Minssen

Professor

ORCID: 0000-0002-3286-4888
201 - 250 out of 413Page size: 50
Sort by: Type
  1. Lecture and oral contribution

  2. Secondary Protection for Innovation in Germany: Problem or Solution?

    Minssen, Timo (Panel member)

    22 Jan 2013

    Activity: Talk or presentation types › Lecture and oral contribution

  3. Sector inquiry on the provision of private health services and related insurance services by Hellenic Competition Commission

    Minssen, Timo (Other)

    26 Oct 2021

    Activity: Talk or presentation types › Lecture and oral contribution

  4. Sectorplan workshop on EU health data governance & the proposed European Health Data Space

    Minssen, Timo (Invited speaker)

    10 Nov 2021

    Activity: Talk or presentation types › Lecture and oral contribution

  5. Shaping the future of Open-Innovation : does the IP legal framework need remodeling?

    Minssen, Timo (Panel member)

    1 Dec 2015

    Activity: Talk or presentation types › Lecture and oral contribution

  6. Should it be possible to patent genes? (Suffolk University Summer School 2008)

    Minssen, Timo (Lecturer)

    1 Jul 2008

    Activity: Talk or presentation types › Lecture and oral contribution

  7. Sourcing Samples from Global Tissue Economies: Legal aspects of the “Global Genes, Local Concerns Project”- Global Biobanking Summit. London.

    Minssen, Timo (Speaker)

    8 May 2014

    Activity: Talk or presentation types › Lecture and oral contribution

  8. Specialdomstole og patentret

    Minssen, Timo (Speaker)

    20 Nov 2014

    Activity: Talk or presentation types › Lecture and oral contribution

  9. Standardization and open innovation in Synthetic Biology

    Minssen, Timo (Lecturer)

    11 Oct 2013

    Activity: Talk or presentation types › Lecture and oral contribution

  10. Standing in the Shadows of Brüstle? – The effect of the CJEU judgment in Brüstle v. Greenpeace on European Patents, Stem Cell Research & Pharmaceutical R&D (presented to the Committee for Advanced Therapies (CAT) at the EMA, London): A presentation prepared for the Committee for Advanced Therapies (CAT) at the European Medicines Agency (EMA), London, UK.

    Minssen, Timo (Speaker)

    14 Sep 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  11. Stanford Responsible Quantum Technology Conference

    Minssen, Timo (Other)

    22 May 2023

    Activity: Talk or presentation types › Lecture and oral contribution

  12. Stem cell patents and the European Biotech Directive

    Minssen, Timo (Speaker)

    30 Jan 2013

    Activity: Talk or presentation types › Lecture and oral contribution

  13. Synthesizing the Law for Synthetic Biology? – An introduction to emerging legal challenges

    Minssen, Timo (Lecturer)

    26 Nov 2013

    Activity: Talk or presentation types › Lecture and oral contribution

  14. Synthetic Biology and Open Innovation: Presentation at University of Cambridge

    Minssen, Timo (Panel member)

    28 Jan 2016

    Activity: Talk or presentation types › Lecture and oral contribution

  15. Taking on the challenges to biomedical innovation- A new Center for Advanced Studies in Biomedical Innovation Law (CeBIL) at UCPH - Talk at Yale Club of New York

    Minssen, Timo (Invited speaker)

    11 Sep 2017

    Activity: Talk or presentation types › Lecture and oral contribution

  16. Technology-Driven Disruption of Healthcare & "UI Layer" Privacy-by-Design

    Corrales Compagnucci, Marcelo (Speaker), Fenwick, M. (Other), Haapio, H. (Other), Minssen, Timo (Other) & Vermeulen, E. P. M. (Other)

    27 Feb 2020

    Activity: Talk or presentation types › Lecture and oral contribution

  17. The Approval of Biosimilars in the US – novel guidelines and developments

    Minssen, Timo (Lecturer)

    15 Aug 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  18. The CAFC's decision in the "Myriad" gene patenting case: Background, outcome and ramifications

    Minssen, Timo (Speaker)

    16 Sep 2011

    Activity: Talk or presentation types › Lecture and oral contribution

  19. The CJEU in Brüstle v. Greenpeace: Legal context, outcome & implications

    Minssen, Timo (Speaker)

    21 Mar 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  20. The CeBIL Center at the University of Copenhagen: Future plans & potential collaborations with BU's Institute for Health System Innovation & Policy (IHSIP) & the Social Innovation on Drug Resistance Program (Boston-SIDR)

    Minssen, Timo (Invited speaker)

    4 Feb 2019

    Activity: Talk or presentation types › Lecture and oral contribution

  21. The CoNeXT project: Legal challenges in interdisciplinary settings, Danish Young Academy of Sciences

    Yu, H. (Speaker), Wested, Jakob (Speaker) & Minssen, Timo (Panel member)

    1 Nov 2017

    Activity: Talk or presentation types › Lecture and oral contribution

  22. The Collaborative Research Programme in Biomedical Innovation Law (CeBIL)- Past, Presence & Future Visions

    Minssen, Timo (Invited speaker)

    9 Nov 2017

    Activity: Talk or presentation types › Lecture and oral contribution

  23. The EPO’s plausibility approach and the industrial application requirement in biotech patenting

    Minssen, Timo (Lecturer)

    13 Aug 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  24. The European assessment of "inventive step"

    Minssen, Timo (Speaker)

    7 Feb 2015 → 11 Feb 2015

    Activity: Talk or presentation types › Lecture and oral contribution

  25. The Importance of Social Sciences for a One Health Approach to Antimicrobial Resistance

    Minssen, Timo (Other)

    18 Aug 2020

    Activity: Talk or presentation types › Lecture and oral contribution

  26. The Patent Governance of Genome Editing Technologies

    Minssen, Timo (Other)

    9 Jun 2022

    Activity: Talk or presentation types › Lecture and oral contribution

  27. The Patent-Eligibility of Dosage Regimes and Diagnostic Methods in the U.S. & Europe

    Minssen, Timo (Speaker)

    13 Sep 2011

    Activity: Talk or presentation types › Lecture and oral contribution

  28. The Proposed EU IP Exception for Generics & Biosimilars Exports - A Cure Worse Than the Disease? (at UC Irvine)

    Minssen, Timo (Invited speaker)

    8 Feb 2019

    Activity: Talk or presentation types › Lecture and oral contribution

  29. The Scope of Protection for Biotech-Patents after Monsanto v. Cefetra

    Minssen, Timo (Speaker)

    8 Nov 2011

    Activity: Talk or presentation types › Lecture and oral contribution

  30. The UPCA’s ”opt out” and “opt-in” provisions - Impact and strategies for European patent portfolios.

    Minssen, Timo (Lecturer)

    7 Oct 2014

    Activity: Talk or presentation types › Lecture and oral contribution

  31. The US Supreme Court in FTC v. Actavis - Context, outcome & implications

    Minssen, Timo (Lecturer)

    18 Jun 2013

    Activity: Talk or presentation types › Lecture and oral contribution

  32. The industrial application requirement for biotech inventions in light of recent EPO & UK case law: A plausible "hunting license"?

    Minssen, Timo (Lecturer)

    12 Aug 2013

    Activity: Talk or presentation types › Lecture and oral contribution

  33. The legal dimension of large European Research Infrastructures and the CoNext project

    Minssen, Timo (Speaker)

    31 Oct 2014

    Activity: Talk or presentation types › Lecture and oral contribution

  34. The legal dimensions of Big Data: University of Copenhagen

    Minssen, Timo (Lecturer)

    20 May 2016

    Activity: Talk or presentation types › Lecture and oral contribution

  35. The legal ecology of resistance, or why normal IP rules should not apply to antibiotics- An IP seminar at the University of Oxford

    Minssen, Timo (Speaker)

    25 Apr 2014

    Activity: Talk or presentation types › Lecture and oral contribution

  36. The legal method of "Law & Technology"

    Minssen, Timo (Lecturer)

    6 Jun 2013

    Activity: Talk or presentation types › Lecture and oral contribution

  37. The massive Impact of Brexit on Danish & UK life science corporations & collaborations

    Minssen, Timo (Invited speaker) & Bostyn, Sven (Invited speaker)

    10 Dec 2018

    Activity: Talk or presentation types › Lecture and oral contribution

  38. The new Centre for Advanced Studies in Biomedical Innovation Law (CeBIL): Where we come from - What we do - Where we want to go.

    Minssen, Timo (Speaker) & Wested, Jakob (Speaker)

    25 May 2018

    Activity: Talk or presentation types › Lecture and oral contribution

  39. The patent eligibility of human embryonic stem cell technology in Europe

    Minssen, Timo (Lecturer)

    13 Aug 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  40. The patent eligibility of human embryonic stem cell technology in Europe - What happened after Brüstle?

    Minssen, Timo (Lecturer)

    12 Aug 2013

    Activity: Talk or presentation types › Lecture and oral contribution

  41. The patentability of personalized medicine in Europe - Dosage regimes and genetic diagnostic methods

    Minssen, Timo (Lecturer)

    13 Aug 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  42. U.S. regulation and patentability of human embryonic stem cell research

    Minssen, Timo (Speaker)

    21 Mar 2012

    Activity: Talk or presentation types › Lecture and oral contribution

  43. US decisions in Sequenom Inc v Ariosa Diagnostics Inc- What now?: University of Cambridge (UK)

    Minssen, Timo (Invited speaker)

    6 Sep 2016

    Activity: Talk or presentation types › Lecture and oral contribution

  44. Utility Model Protection in Danish Law at LSE

    Minssen, Timo (Other)

    2 Feb 2023

    Activity: Talk or presentation types › Lecture and oral contribution

  45. WHO panel on the governance of gene editing

    Minssen, Timo (Other)

    2021

    Activity: Talk or presentation types › Lecture and oral contribution

  46. Welcome to the Machine! – Artificial Intelligence, Health Innovation & the Law

    Minssen, Timo (Invited speaker)

    16 Nov 2018

    Activity: Talk or presentation types › Lecture and oral contribution

  47. What's next for CoNeXT: The final phase of the legal part of the CoNeXT project: Achievements, ambitions and the way forward.

    Minssen, Timo (Lecturer)

    10 Oct 2016

    Activity: Talk or presentation types › Lecture and oral contribution

  48. When Does Follow-On Pharmaceutical Innovation Deserve Patent Protection, And Why?

    Minssen, Timo (Other)

    4 Feb 2020

    Activity: Talk or presentation types › Lecture and oral contribution

  49. Workshop on The International Health Regulations: Analysis and Commentary

    Minssen, Timo (Invited speaker)

    2021

    Activity: Talk or presentation types › Lecture and oral contribution

  50. “AI in the Medical Sciences & the Lex Machina”

    Minssen, Timo (Invited speaker)

    20 Nov 2018

    Activity: Talk or presentation types › Lecture and oral contribution

  51. “Early Publishing of Clinical Trial Data, Striking the Balance between Patent Protection & the Wider Public Interest”: C5 Life Science IP Summit 2016 in London

    Minssen, Timo (Panel member)

    20 Oct 2016

    Activity: Talk or presentation types › Lecture and oral contribution

Previous 1 2 3 4 5 6 7 8 9 Next

ID: 16150437